ThomasPNifongMD

Pathology • Cambridge, MA

Anatomic Pathology, Clinical Pathology

EVP Diagnostic Tests, Definiens

Join to view full profile

Dr. Nifong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nifong's full profile

Already have an account?

Office
125 CambridgePark Dr Suite 300
Cambridge, MA 02140
Phone+1 717-512-3945
Is this information wrong?

Education & Training

Penn State Milton S Hershey Medical CenterResidency, Pathology-Anatomic and Clinical, 1997 - 2000
Penn State Milton S Hershey Medical CenterResidency, Anesthesiology, 1996 - 1999
Highland Hospital of RochesterInternship, Internal Medicine, 1995 - 1996
University of Rochester School of Medicine and DentistryClass of 1995

Certifications & Licensure

PA State Medical License 1999 - 2024
MA State Medical License 2011 - 2018
FL State Medical License 2012 - 2016
CA State Medical License 2013 - 2016
GA State Medical License 2013 - 2015
American Board of Pathology Clinical Pathology

Publications & Presentations

PubMed

115 citations
Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer
Peter Blume-Jensen, David M. Berman, David L. Rimm, Michail Shipitsin, Mathew Putzi, Thomas P. Nifong, Clayton Small, Sibgat Choudhury, Teresa Capela, Louis Coupal, Ch...> ;Clinical Cancer Research. 2015 Mar 2
100 citations
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
Michail Shipitsin, Catherine B. Small, Sibgat Choudhury, Eldar Giladi, S Friedlander, Julie Nardone, Shaun A. Hussain, Aeron D. Hurley, Christina Ernst, Y E Huang, H. ...> ;British Journal of Cancer. 2014 Sep 9
48 citations
Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer letha...
Michail Shipitsin, Clayton Small, Eldar Giladi, Summar Siddiqui, Sibgat Choudhury, Sadiq Hussain, Yi E Huang, Hua Chang, David L. Rimm, David M. Berman, Thomas P. Nifo...> ;Proteome Science. 2014 Jul 12
63 citations
Vessel Health and Preservation (Part 1): A New Evidence-Based Approach to Vascular Access Selection and Management:
Nancy Moureau, Nancy Trick, Thomas P. Nifong, Cathy Perry, Cheryl Kelley, Ruth Carrico, Michael Leavitt, Steven M. Gordon, Jessica E Wallace, Monte Harvill, Connie Big...> ;The Journal of Vascular Access. 2012 Feb 1
9 citations
Chronic in vivo testing of the Penn State infant ventricular assist device.
William J. Weiss, Elizabeth L. Carney, J. Brian Clark, Rebecca Peterson, Timothy K. Cooper, Thomas P. Nifong, Christopher A. Siedlecki, Dennis Hicks, Bradley Doxtater,...> ;ASAIO Journal. 2012 Jan 1
142 citations
The Effect of Catheter to Vein Ratio on Blood Flow Rates in a Simulated Model of Peripherally Inserted Central Venous Catheters
Thomas P. Nifong, Timothy McDevitt> ;Chest. 2011 Jul 1
6 citations
Composite EBV negative peripheral T-cell lymphoma and diffuse large B-cell lymphoma involving the ileum: A case report and a systematic review of the literature
Ashraf A. Abou-Elella, Thomas P. Nifong> ;Leukemia & Lymphoma. 2006 Oct 1
10 citations
Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation.
Thomas P. Nifong, W. Christopher Ehmann, Joseph Mierski, Ronald E. Domen, Witold B. Rybka> ;Archives of Pathology & Laboratory Medicine. 2003 Jan 1
33 citations
Coagulant stability and sterility of thawed S/D-treated plasma.
Thomas P. Nifong, Jan Light, Robert E. Wenk> ;Transfusion. 2002 Dec 1
3 citations
Separation of IgG and IgM from albumin in citrated human plasma using electrodialysis and metal ion affinity precipitation.
Thomas P. Nifong, Glenn S. Gerhard> ;ASAIO Journal. 2002 Nov 1
14 citations
Oxygen saturation and hemoglobin A content in patients with sickle cell disease undergoing erythrocytapheresis.
Thomas P. Nifong, Ronald E. Domen> ;Therapeutic Apheresis. 2002 Oct 1
6 citations
Durable response to combination therapy including staphylococcal protein A immunoadsorption in life-threatening refractory autoimmune hemolysis.
Mansoor Javeed, Thomas P. Nifong, Ronald E. Domen, Witold B. Rybka> ;Transfusion. 2002 Sep 1
3 citations
Mathematical modeling and computer simulation of erythrocytapheresis for SCD.
Thomas P. Nifong, Michael B. Bongiovanni, Glenn S. Gerhard> ;Transfusion. 2001 Feb 1
Physical determinants of line pressures during apheresis.
Thomas P. Nifong, Glenn S. Gerhard> ;Transfusion Science. 1999 Jun 1
Immunochemical evaluation of S-antigen of rabbit pineal gland
Patricia A. Gollin, Harminder S Dua, Thomas P. Nifong, Carolyn M. Kalsow> ;Ocular Immunology and Inflammation. 1995 Jan 1
11 citations
Pinealitis coincident with recurrent uveitis: immunohistochemical studies.
Carolyn M. Kalsow, Ann E. Dwyer, Andrew W. Smith, Thomas P. Nifong> ;Current Eye Research. 1992 Jan 1
Pinealitis accompanying equine recurrent uveitis.
Kalsow, C. M., Dwyer, A. E., Smith, A. W., Nifong, T. P.> ;Br J Ophthalmol. 1993 Jan
Join now to see all